[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575997":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":10,"centralContacts":23,"locations":29,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":10,"eligibilityCriteria":53,"healthyVolunteers":50,"sex":54,"minAge":55,"maxAge":10,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Abbott Medical Devices","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment Group",null,"Heart failure patients implanted with the CardioMEMS PA pressure sensor.",[13],"Device: CardioMEMS HF System",{"label":15,"type":10,"description":16,"interventionNames":10},"Control Group","Heart failure patients being managed without PA pressure-monitoring.",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"DEVICE","CardioMEMS HF System","PA Pressure Sensor",[9],[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Nessa Johnson","CONTACT","612-283-3865","nessa.johnson@abbott.com",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Abbott","RECRUITING","Pleasanton","California","94588","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-121.87468,37.66243,{"lat":42,"lon":41},[45],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100575997","cardiomems-hf-system-coverage-with-evidence-development-study-100575997",false,"NCT06779552","CardioMEMS HF System Coverage With Evidence Development Study","Inclusion Criteria:\n\n1. Subject implanted with a CardioMEMS pressure sensor (treatment arm only)\n2. Subject \\>=18 years of age at time of implant\n3. Subject has a history of acute decompensated HF or HF-related congestion defined by at least one of the following qualifying event types: HF hospitalization, elevated BNP\u002FNT-proBNP\n\nExclusion Criteria:\n\n1. Subject has history of heart transplant or durable mechanical circulatory device\n2. Subject hospitalized with cardiogenic shock or sepsis\n3. Subject received prior PA pressure sensor implant (control arm only)","ALL","18 Years",{"count":57,"type":58},1000,"ESTIMATED","OBSERVATIONAL","The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.",[62],"Heart Failure","2026-03-30",{"date":65,"type":66},"2026-04-03","ACTUAL",{"date":68,"type":66},"2025-02-07",{"date":70,"type":58},"2032-03",{"name":5,"class":6},1]